Company
United StatesPublic company, NASDAQ: CELCCelcuity Inc. (NASDAQ: CELC), Minneapolis, MN – FDA Inspections
Inspection records and compliance data for Celcuity Inc. in Minneapolis, MN. 1 FDA inspection on record, last inspected February 12, 2026. Publicly traded as NASDAQ: CELC.
Company Profile
This profile covers Celcuity Inc. based in Minneapolis, MN, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected February 12, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 12, 2026 | Not classified | Human Drugs | 1304676 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Celcuity Inc.
Stock ticker
CELC
Exchange
NASDAQ
Share price
$64.17
Market cap
$3.2B
Price as of
November 13, 2026
FEI Number
3012100102
Address
16305 36th Ave N Ste 100, Minneapolis, MN 55446-4285, United States
Country
United States
ID: f8dc272b-60f8-4be6-9b09-574d190b63f1